Clinical Trials Browser

Interventional × romidepsin × 30 days × Clear all

NCT03547700 2026-05-06

Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL)

Phase 1/2 Terminated

11 enrolled 10 charts

Lymphoma, T-Cell, Peripheral